158 related articles for article (PubMed ID: 16633504)
21. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
Chisholm D; Rehm J; Van Ommeren M; Monteiro M
J Stud Alcohol; 2004 Nov; 65(6):782-93. PubMed ID: 15700517
[TBL] [Abstract][Full Text] [Related]
22. Scaling up malaria intervention "packages" in Senegal: using cost effectiveness data for improving allocative efficiency and programmatic decision-making.
Faye S; Cico A; Gueye AB; Baruwa E; Johns B; Ndiop M; Alilio M
Malar J; 2018 Apr; 17(1):159. PubMed ID: 29636051
[TBL] [Abstract][Full Text] [Related]
23. How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition's Lung Facts.
Franklin M; Angus C; Welte T; Joos G
Appl Health Econ Health Policy; 2023 Jul; 21(4):547-558. PubMed ID: 37039953
[TBL] [Abstract][Full Text] [Related]
24. Thresholds for the cost-effectiveness of interventions: alternative approaches.
Marseille E; Larson B; Kazi DS; Kahn JG; Rosen S
Bull World Health Organ; 2015 Feb; 93(2):118-24. PubMed ID: 25883405
[TBL] [Abstract][Full Text] [Related]
25. Breastfeeding promotion and priority setting in health.
Horton S; Sanghvi T; Phillips M; Fiedler J; Perez-Escamilla R; Lutter C; Rivera A; Segall-Correa AM
Health Policy Plan; 1996 Jun; 11(2):156-68. PubMed ID: 10158457
[TBL] [Abstract][Full Text] [Related]
26. Human and Economic Cost of Disease Burden Due to Congenital Hypothyroidism in India: Too Little, but Not Too Late.
Vidavalur R
Front Pediatr; 2022; 10():788589. PubMed ID: 35592841
[TBL] [Abstract][Full Text] [Related]
27. Assessing cost-effectiveness of drug interventions for schizophrenia.
Magnus A; Carr V; Mihalopoulos C; Carter R; Vos T
Aust N Z J Psychiatry; 2005; 39(1-2):44-54. PubMed ID: 15660705
[TBL] [Abstract][Full Text] [Related]
28. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
[TBL] [Abstract][Full Text] [Related]
29. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
30. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
[TBL] [Abstract][Full Text] [Related]
31. Country contextualisation of cost-effectiveness studies: lessons from Ethiopia.
Johansson KA; Tolla MT; Memirie ST; Miljeteig I; Habtemariam MK; Woldemariam AT; Verguet S; Norheim OF
BMJ Glob Health; 2019; 4(6):e001320. PubMed ID: 31908853
[TBL] [Abstract][Full Text] [Related]
32. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
[TBL] [Abstract][Full Text] [Related]
35. Cost Per DALY Averted in a Surgical Unit of a Private Hospital in India.
Chatterjee S; Laxminarayan R; Gosselin RA
World J Surg; 2016 May; 40(5):1034-40. PubMed ID: 26675929
[TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of intensified dengue control measures with interrupted time series analysis in the Panadura Medical Officer of Health division in Sri Lanka: a case study and cost-effectiveness analysis.
Liyanage P; Rocklöv J; Tissera H; Palihawadana P; Wilder-Smith A; Tozan Y
Lancet Planet Health; 2019 May; 3(5):e211-e218. PubMed ID: 31128766
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
